help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuller, P. J.
Right arrow Articles by Burger, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuller, P. J.
Right arrow Articles by Burger, H. G.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 1 274-279
Copyright © 1998 by The Endocrine Society

Original Studies

No Evidence of a Role for Mutations or Polymorphisms of the Follicle-Stimulating Hormone Receptor in Ovarian Granulosa Cell Tumors1

Peter J. Fuller2, Karen Verity, Yan Shen3, Pamela Mamers, Tom Jobling and Henry G. Burger

Prince Henry’s Institute of Medical Research, Monash University, and Department of Obstetrics and Gynecology, Monash Medical Center, Clayton, Victoria 3168, Australia

Address all correspondence and requests for reprints to: Dr. Peter J. Fuller, Prince Henry’s Institute of Medical Research, P.O. Box 5152, Clayton, Victoria 3168, Australia. E-mail: peter.fuller{at}med.monash.edu.au

The molecular pathogenesis of granulosa cell tumors of the ovary is not understood, although recent studies have shown that immunoreactive inhibin secretion by these tumors may be used as a tumor marker. Granulosa cell tumors exhibit many features of normal granulosa cells, including a response to FSH and inhibin secretion. FSH levels are suppressed in patients with inhibin-secreting granulosa cell tumors, suggesting FSH-independent growth of these tumors. Activating mutations of the FSH receptor might, therefore, be involved in tumorigenesis. We sought to identify mutations in the FSH receptor genes of these tumors using PCR to amplify the exon encoding the transmembrane and cytoplasmic domains from the tumor DNA. Analysis of the amplicons for single strand conformational polymorphisms and direct sequencing confirmed a previously reported polymorphism in the C-terminal region of the receptor, but did not identify tumor-specific missense mutations and/or polymorphisms. In addition, ribonucleic acid from 3 granulosa cell tumors was used to confirm expression of the FSH receptor; expression was unexpectedly also observed in several ovarian mucinous cystadenocarcinomas used as controls. In conclusion, our failure to identify activating mutations of the FSH receptor in 15 granulosa cell tumors argues against a role for the FSH receptor in tumorigenesis and suggests that some subsequent component of this signal transduction pathway may be activated.




This article has been cited by other articles:


Home page
 CarcinogenesisHome page
M.-N. Lague, M. Paquet, H.-Y. Fan, M. J. Kaartinen, S. Chu, S. P. Jamin, R. R. Behringer, P. J. Fuller, A. Mitchell, M. Dore, et al.
Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression
Carcinogenesis, November 1, 2008; 29(11): 2062 - 2072.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Zhang, Y.-X. Tao, G. L. Ryan, X. Feng, F. Fanelli, and D. L. Segaloff
Intrinsic Differences in the Response of the Human Lutropin Receptor Versus the Human Follitropin Receptor to Activating Mutations
J. Biol. Chem., August 31, 2007; 282(35): 25527 - 25539.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A. M Dorward, K. L Shultz, and W. G Beamer
LH analog and dietary isoflavones support ovarian granulosa cell tumor development in a spontaneous mouse model
Endocr. Relat. Cancer, June 1, 2007; 14(2): 369 - 379.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J.-H. Choi, A. S. T. Wong, H.-F. Huang, and P. C. K. Leung
Gonadotropins and Ovarian Cancer
Endocr. Rev., June 1, 2007; 28(4): 440 - 461.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C.Q. Yang, K.Y.K. Chan, H.Y.S. Ngan, U.S. Khoo, P.M. Chiu, Q.K.Y. Chan, W.C. Xue, and A.N.Y. Cheung
Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility
Carcinogenesis, July 1, 2006; 27(7): 1502 - 1506.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Kalfa, A. Ecochard, C. Patte, P. Duvillard, F. Audran, C. Pienkowski, E. Thibaud, R. Brauner, C. Lecointre, D. Plantaz, et al.
Activating Mutations of the Stimulatory G Protein in Juvenile Ovarian Granulosa Cell Tumors: A New Prognostic Factor?
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1842 - 1847.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Anttonen, L. Unkila-Kallio, A. Leminen, R. Butzow, and M. Heikinheimo
High GATA-4 Expression Associates with Aggressive Behavior, whereas Low Anti-Mullerian Hormone Expression Associates with Growth Potential of Ovarian Granulosa Cell Tumors
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6529 - 6535.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Boerboom, M. Paquet, M. Hsieh, J. Liu, S. P. Jamin, R. R. Behringer, J. Sirois, M. M. Taketo, and J. S. Richards
Misregulated Wnt/{beta}-Catenin Signaling Leads to Ovarian Granulosa Cell Tumor Development
Cancer Res., October 15, 2005; 65(20): 9206 - 9215.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
S. Sudo, M. Kudo, S.-i. Wada, O. Sato, A. J.W. Hsueh, and S. Fujimoto
Genetic and functional analyses of polymorphisms in the human FSH receptor gene
Mol. Hum. Reprod., October 1, 2002; 8(10): 893 - 899.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Y.-X. Tao, D. Mizrachi, and D. L. Segaloff
Chimeras of the Rat and Human FSH Receptors (FSHRs) Identify Residues that Permit or Suppress Transmembrane 6 Mutation-Induced Constitutive Activation of the FSHR via Rearrangements of Hydrophobic Interactions Between Helices 6 and 7
Mol. Endocrinol., August 1, 2002; 16(8): 1881 - 1892.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
G. E. Owens, R. A. Keri, and J. H. Nilson
Ovulatory Surges of Human CG Prevent Hormone-Induced Granulosa Cell Tumor Formation Leading to the Identification of Tumor-Associated Changes in the Transcriptome
Mol. Endocrinol., June 1, 2002; 16(6): 1230 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
S. Chu, S. Rushdi, E.T. Zumpe, P. Mamers, D.L. Healy, T. Jobling, H.G. Burger, and P.J. Fuller
FSH-regulated gene expression profiles in ovarian tumours and normal ovaries
Mol. Hum. Reprod., May 1, 2002; 8(5): 426 - 433.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. J. Fuller, E. T. Zumpe, S. Chu, P. Mamers, and H. G. Burger
Inhibin-Activin Receptor Subunit Gene Expression in Ovarian Tumors
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1395 - 1401.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. S. Choong, P. J. Fuller, S. Chu, Y. Jeske, F. Bowling, R. Brown, P. Borzi, N. D. Balazs, R. Suppiah, A. M. Cotterill, et al.
Sertoli-Leydig Cell Tumor of the Ovary, a Rare Cause of Precocious Puberty in a 12-Month-Old Infant
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 49 - 56.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. P. N. Themmen and I. T. Huhtaniemi
Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function
Endocr. Rev., October 1, 2000; 21(5): 551 - 583.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
J. L. Juengel, L. D. Quirke, D. J. Tisdall, P. Smith, N. L. Hudson, and K. P. McNatty
Gene Expression in Abnormal Ovarian Structures of Ewes Homozygous for the Inverdale Prolificacy Gene
Biol Reprod, June 1, 2000; 62(6): 1467 - 1478.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Chu, P. Mamers, H. G. Burger, and P. J. Fuller
Estrogen Receptor Isoform Gene Expression in Ovarian Stromal and Epithelial Tumors
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1200 - 1205.
[Abstract] [Full Text]

Home page
 Mol Hum ReprodHome page
H. Zhang, M. Vollmer, M. De Geyter, Y. Litzistorf, A. Ladewig, M. Durrenberger, R. Guggenheim, P. Miny, W. Holzgreve, and C. De Geyter
Characterization of an immortalized human granulosa cell line (COV434)
Mol. Hum. Reprod., February 1, 2000; 6(2): 146 - 153.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Hussein, S. Chu, and P. J. Fuller
Comment on Analysis of Mutations in Genes of the Follicle-Stimulating Hormone Receptor in Ovarian Granulosa Cell Tumors
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3852 - 3853.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. J. Ligtenberg, M. Siers, A. P. N. Themmen, T. G. Hanselaar, W. Willemsen, and H. G. Brunner
Analysis of Mutations in Genes of the Follicle-Stimulating Hormone Receptor Signaling Pathway in Ovarian Granulosa Cell Tumors
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2233 - 2234.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society